Vitamin D replacement for adolescent females with PCOS and low vitamin D
Official title: Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
Run by Yale University · NCT04355572 · Data updated 2026-11-12
This study will try daily vitamin D (4,000 IU) versus placebo in adolescent females ages 13–21 who have PCOS and low vitamin D to see if it improves hormone and metabolic blood tests over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 21 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | August 31, 2028 |
| Study ends | August 31, 2028 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT04355572 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Postmenarchal adolescent females aged 13–21 who meet modified Rotterdam criteria for PCOS and have a serum vitamin D level between 6 and 29 ng/mL, without other causes of hyperandrogenism or calcium/vitamin D metabolic disorders.
✕Probably not a fit
Patients with very low vitamin D (≤5 ng/mL), other causes of hyperandrogenism, chronic renal disease, or known calcium/vitamin D metabolic disorders are excluded and would not be expected to benefit from this randomized comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a double-blind, randomized, placebo-controlled trial at Yale New Haven Children's Hospital enrolling postmenarchal females (13–21) who meet modified Rotterdam criteria for PCOS and have serum vitamin D 6–29 ng/mL. Participants are randomized to 4,000 IU vitamin D daily or matching placebo and followed for six months with lab testing at baseline, 3 months, and 6 months. Key measurements include AMH, vitamin D, lipid profile, glucose and insulin, androgen testing, and female hormone testing while participants and investigators remain blinded. Patients with severe deficiency (≤5 ng/mL) or other exclusionary conditions are managed clinically rather than randomized.
Why it matters
Potential benefit: If successful, vitamin D replacement could improve ovarian hormone markers, menstrual symptoms, and metabolic risk factors in adolescents with PCOS.
How similar studies have gone: Small randomized and observational studies have reported mixed effects of vitamin D on insulin resistance and androgen levels in PCOS, so the approach is plausible but not definitively proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Postmenarchal adolescent females aged 13-21 who meet modified Rotterdam criteria for PCOS, with a serum vitamin D level between 6-29 ng/mL. Exclusion Criteria: * Other causes for hyperandrogenism, * Chronic renal diseases, * Acquired or inherited calcium and vitamin D metabolic disorders.
Where it's running
-
Yale New Haven Children's Hospital
New Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Alla Vash-Margita, MD — Yale University
- Study coordinator: Alla Vash-Margita, MD
- Email: alla.vash-margita@yale.edu
- Phone: 203-785-4010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vitamin D Supplementation in Children with Irritable Bowel Syndrome
This study tests whether giving vitamin D to children with IBS and low vitamin D levels can improve their IBS symptoms compared with a placebo.
-
Vitamin D and dental implant osseointegration in adults with deficiency
This study tests whether giving vitamin D helps improve how well dental implants fuse with bone in adults who are deficient.
-
Vitamin D2 with Calcitriol in kids with cholestasis and vitamin D deficiency
This study tests whether adding calcitriol to vitamin D2 helps children with cholestasis and vitamin D deficiency reach healthier vitamin D levels.
-
Vitamin D and the body's anti-inflammatory response in gum disease
This study tests whether vitamin D can modulate the body's anti-inflammatory response in people with gum disease.
-
Bone Myoregulation and Posture in Vitamin D Deficiency
This observational study tests whether adults with vitamin D deficiency differ in postural stability and muscle activity from healthy controls during a single-session, noninvasive assessment.
-
Adding exercise to vitamin D treatment for diabetic men with erectile dysfunction and low vitamin D.
This trial will see if adding regular moderate treadmill walking to high‑dose vitamin D replacement helps men with type 2 diabetes, chronic erectile dysfunction, and low vitamin D levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.